University Of Oklahoma
Clinical trials sponsored by University Of Oklahoma, explained in plain language.
-
Cancer drug combo tested for rare gene mutation – but trial stopped early
Disease control TerminatedThis study tested two drugs, niraparib and bevacizumab, alone or together, in people with recurrent endometrial or ovarian cancer that has a specific gene change called ARID1A. The goal was to see if the drugs could shrink tumors. However, the trial was stopped early after enroll…
Phase: PHASE2 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Blood sugar tightrope: can intensive control help stem cell patients?
Disease control TerminatedThis study looked at whether keeping blood sugar very tightly controlled (goal of 110 mg/dL) using continuous insulin could help people undergoing stem cell transplants. The researchers wanted to see if it would lower death rates, reduce infections, and shorten hospital stays. Ho…
Phase: NA • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Double shock heart treatment trial fizzles out
Disease control TerminatedThis trial tested whether giving two quick electrical shocks instead of one could better restore a normal heart rhythm in people with atrial fibrillation. It focused on patients with factors that make standard shock treatment less likely to work, such as obesity or lung disease. …
Phase: EARLY_PHASE1 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Alcohol-Dependence drug studied in DUI offenders – study halted early
Disease control TerminatedThis study tested a drug called acamprosate in adults with alcohol dependence who were part of a DUI court program. The goal was to see if the medication could help them stay sober and reduce cravings. Only 4 people enrolled before the study was stopped, so results are very limit…
Phase: NA • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New Light-Based scanner aims to spot inflammation without needles
Diagnosis TerminatedThis study tested a new imaging tool called multispectral optoacoustic tomography (MSOT) to see if it could safely detect inflammation in people with graft-versus-host disease, Crohn's disease, or colitis. The device uses light and sound to create images of inflamed areas. The tr…
Phase: NA • Sponsor: University of Oklahoma • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Could a bronchoscope replace X-Rays for pneumothorax?
Diagnosis TerminatedThis study tested whether the ultrasound tip of an EBUS bronchoscope, placed on the chest, can detect pneumothorax (collapsed lung) as well as a standard ultrasound probe. Researchers enrolled 17 patients, including those with and without pneumothorax. The goal was to see if this…
Sponsor: University of Oklahoma • Aim: Diagnosis
Last updated Jun 27, 2026 12:02 UTC
-
Vibration vest aims to restore arm function in stroke survivors
Symptom relief TerminatedThis study tested a wearable device that uses gentle vibrations to help stroke survivors improve arm strength and movement. The plan was to have 48 people use the device at home for 4 weeks, but only 4 enrolled before the study was stopped. Researchers measured usability and chan…
Phase: NA • Sponsor: University of Oklahoma • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Heart failure nerve stimulation study fizzles out
Symptom relief TerminatedThis study tested if a gentle nerve stimulation (like a mild electrical pulse on the neck) could improve blood vessel health and memory in people with heart failure. Only 7 people took part before the study was stopped early. The goal was to see if 4 weeks of stimulation could re…
Phase: NA • Sponsor: University of Oklahoma • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Pancreatic cancer gene study targets muscle wasting
Knowledge-focused TerminatedThis pilot study aimed to find genetic differences, called microRNAs, that might explain why some pancreatic cancer patients lose muscle mass (cachexia). Researchers planned to analyze tumor samples from 40 patients undergoing surgery, focusing on African Americans who may be at …
Sponsor: University of Oklahoma • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Heartburn drug tested against pancreatic cancer in early trial
Knowledge-focused TerminatedThis early-phase study tested whether high doses of omeprazole, a common heartburn medication, could safely change certain markers in pancreatic tumors. The trial planned to enroll 25 patients with exocrine pancreatic cancer who were scheduled for surgery. Participants took omepr…
Phase: EARLY_PHASE1 • Sponsor: University of Oklahoma • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC